Capricorn Fund Managers Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 1901361 LONDON, X0

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$3,941,808

New position

Shares Held

31,200

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#637

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capricorn Fund Managers Ltd holds $34,667,354 across 6 Drug Manufacturers - General names. GILD ranks #3 (11.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	426,416	$22,352,726
2	ABBV	AbbVie Inc.	27,397	$6,894,181
3	GILD	Gilead Sciences, Inc. This page	31,200	$3,941,808
4	PFE	Pfizer Inc	22,130	$532,890
5	MRK	Merck & Co., Inc.	4,000	$514,000
6	JNJ	Johnson & Johnson	1,700	$431,749

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,941,808	31,200	—	Shares	Sole	2026-07-24
No filing history on record for this holder in this stock.